Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Paraschos Archontakis Barakakis, Thuonghien Tran, Jee Young You, Gabriel J Hernandez Romero, Vipul Gidwani, Fernando J Martinez & Spyridon Fortis. (2023) High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 469-482.
Read now
Read now
Satish Chandra Kilaru, Avya Gopal Bansal, Vaishali Sandeep Naik, Meena Lopez & Jaideep Ashok Gogtay. (2022) A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination. Expert Review of Respiratory Medicine 16:5, pages 529-540.
Read now
Read now
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss & David M G Halpin. (2021) Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 499-517.
Read now
Read now
Qian Zhang, Shuo Li, Wei Zhou, Xia Yang, Jinna Li & Jie Cao. (2020) Risk of Pneumonia with Different Inhaled Corticosteroids in COPD Patients: A Meta-Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:4, pages 462-469.
Read now
Read now
Articles from other publishers (13)
Hong Chen, Zheng-Xu Deng, Jian Sun, Qiang Huang, Lan Huang, Yong-Hong He, Chunlan Ma & Ke Wang. (2023) Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD. Chest 163:1, pages 100-114.
Crossref
Crossref
Robert A. Wise, Mona Bafadhel, Courtney Crim, Gerard J. Criner, Nicola C. Day, David M.G. Halpin, MeiLan K. Han, Peter Lange, David A. Lipson, Fernando J. Martinez, Diego J. Maselli, Dawn Midwinter, Dave Singh, Maeva Zysman, Mark T. Dransfield & Richard E.K. Russell. (2021) Discordant diagnostic criteria for pneumonia in COPD trials: a review. European Respiratory Review 30:162, pages 210124.
Crossref
Crossref
Hong Chen, Jian Sun, Qiang Huang, Yongqi Liu, Mengxin Yuan, Chunlan Ma & Hao Yan. (2021) Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials. Frontiers in Pharmacology 12.
Crossref
Crossref
M. Zysman, B. Ribeiro Baptista, T. Soumagne, V. Marques da Silva, C. Martin, C. Thibault de Menonville, L. Boyer, B. Degano, C. Morelot Panzini, P.R. Burgel, T. Perez, A. Bourdin, C. Raherison, H. Pégliasco, D. Piperno, C. Zanetti, H. Morel, B. Delclaux, C. Delafosse, A. Lorenzo, B. Housset, F. Chabot, P. Devillier, G. Deslée & N. Roche. (2021) Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021. Revue des Maladies Respiratoires 38:5, pages 539-561.
Crossref
Crossref
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 267, pages 118973.
Crossref
Crossref
Tao Liu, Zi-Jian Xiang, Xiao-Meng Hou, Jing-Jing Chai, Yan-Li Yang & Xiao-Tong Zhang. (2021) Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease 12, pages 204062232110287.
Crossref
Crossref
Timothy H. Harries, Victoria Rowland, Christopher J. Corrigan, Iain J. Marshall, Lucy McDonnell, Vibhore Prasad, Peter Schofield, David Armstrong & Patrick White. (2020) Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respiratory Research 21:1.
Crossref
Crossref
Takudzwa Mkorombindo & Mark T. Dransfield. (2020) Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 41:3, pages 475-484.
Crossref
Crossref
Linda M. Nelsen, Laurie A. Lee, Wei Wu, Xiwu Lin, Lindsey Murray, Steven J. Pascoe & Nancy K. Leidy. (2019) Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap. Respiratory Research 20:1.
Crossref
Crossref
Stefan M. Frent, Kenneth R. Chapman, Michael Larbig, Alexander Mackay, Robert Fogel, Florian S. Gutzwiller, Steven Shen, Francesco Patalano, Donald Banerji, Konstantinos Kostikas & Jadwiga A. Wedzicha. (2019) Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME. American Journal of Respiratory and Critical Care Medicine 199:1, pages 43-51.
Crossref
Crossref
Yuji Oba, Edna Keeney, Namratta Ghatehorde & Sofia Dias. (2018) Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Alvar Agusti, Leonardo M. Fabbri, Dave Singh, Jørgen Vestbo, Bartolome Celli, Frits M.E. Franssen, Klaus F. Rabe & Alberto Papi. (2018) Inhaled corticosteroids in COPD: friend or foe?. European Respiratory Journal 52:6, pages 1801219.
Crossref
Crossref
Mohamed Bayoumi-Ali, Richard John Sweeney, Luqman Hussain Wali, Doaa Farag & Favas Thaivalappil. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
217
227
.